Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Co-administration of CoronaVac and Inlive in Children
NCT05107557Phase 4Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Nov 2021
- Primary completion
- Dec 2021
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of coronavac, enterovirus 71 vaccine (vero cell), inactivated in coronavirus disease 2019 (COVID-19), HIV-associated central nervous system involvement (HAND), sponsored by Sinovac Biotech Ltd.. Started Nov 2021; status: completed.
02
Drugs
coronavacenterovirus 71 vaccine (vero cell), inactivated
03
Conditions
coronavirus disease 2019 (COVID-19)HIV-associated central nervous system involvement (HAND)
Beyond the preview
Go deeper on NCT05107557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05107557.